Webinar: Clinical evaluation and clinical investigation of medical devices

Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.

Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma

Webinar | March 13, 2024, 12 PM EST.

RegFile AB

Ozempic may benefit hip replacement surgery

The high-profile drug for type 2 diabetes and weight loss may be beneficial in other areas. One such area is for patients undergoing hip replacement surgery, a ...

Suing the company – for NOT developing a new HIV drug

Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...

Microscope or Measuring Machine? Both!

Watch our demo recording with features, software and best-practices.

Behöver du vätskekylning under noll grader?

SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!

A vaccine the world is waiting for: “It can change the lives of many”

A Solna laboratory is developing a vaccine that could save the lives of countless children in low- and middle-income countries. “Working on something that can m...

ZEISS Quality Innovation Days: April 15 – 19, 2024

Be there when industry experts give exciting insights into different applications and trends in 90 minutes on various theme days.

He got inside the head of Sweden’s vaccine hunter

The hunt for the COVID-19 vaccine is the theme of the new book Vaccinjägaren (The Vaccine Hunter). It tells the story of Richard Bergström’s mission as Sweden’s...

Product demo with features, software and best-practices

Get interesting insights about ZEISS O-INSPECT duo in our demo recording.

Vd-byte i stamcellsbolag

Biotechbolaget Biolamina har utsett Klaus Langhoff-Roos till ny vd.

AI speeds up measurement process

How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.

Ny chef för NIH lovar omfattande reformer

Läkaren Jay Bhattacharya utses av Donald Trump att leda USA:s forskningsinstitut NIH, med en budget på nära 50 miljarder dollar, som han lovar att reformera i grunden.

AI-företag köper tillgång till vetenskapliga studier – ”Svårt att reagera som forskare”

Stora förlag för vetenskapliga tidskrifter har i miljonaffärer sålt tillgång till studier till techbolag som utvecklar AI-verktyg. Reaktionerna bland svenska fo...

Study: Popular diabetes drug may be effective against liver disease

After its success in diabetes and weight loss, a new potential therapeutic area has been identified for Ozempic and other GLP1 analogues. A new study links the ...

Dicots nyemission övertecknad – "Vi har stor tillförsikt"

Investeringsklimatet sägs vara ogästvänligt på sina håll i branschen, men det gäller inte Uppsalabolaget Dicot Pharma och dess potensläkemedel under utveckling....

Eliceras cancerterapi utvärderas i Kina – "Bred potential"

Göteborgsbaserade Elicera Therapeutics inleder ett samarbete med ett kinesiskt universitet om utveckling av bolagets onkologiska virusterapi ELC-201.

Bioarctic går vidare med parkinsonkandidat efter lyckad fas I-studie

Bioarctic meddelar positiva studieresultat i tidig klinisk fas för sin läkemedelskandidat mot Parkinsons sjukdom.

Lista: Här är biotechbolagen som startade i Sverige förra året

Tuffa ekonomiska tider och försiktiga investerare drabbar små biotechbolag. Trots detta finns det företagare som vågar satsa och starta nytt. Life Science Swede...

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.

Quotient Sciences Limited

ZEISS presents the "Quality Innovation Days"

The digital event for metrology and software.

Improved processes and more

Discover the full potential and benefits.